InvestorsHub Logo
Followers 7
Posts 348
Boards Moderated 0
Alias Born 08/12/2022

Re: None

Wednesday, 08/17/2022 5:59:02 PM

Wednesday, August 17, 2022 5:59:02 PM

Post# of 1456
Anticipated Pipeline Milestones

Zilovertamab

• MCL global registrational Phase 3 Study ZILO-301 initiation September 2022


• MCL & CLL clinical data update for ongoing Phase 2 4Q 2022

ONCT-808 ROR1 CAR-T cell therapy
:


• B-Cell malignancies U.S. IND submission August 2022
ONCT-534

• Prostate cancer FDA pre-IND interaction 4Q 2022


$Onct
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCT News